PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 105 filers reported holding PASSAGE BIO INC in Q3 2021. The put-call ratio across all filers is 2.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $119,040 | -72.0% | 38,400 | -42.7% | 0.00% | – |
| Q4 2021 | $425,000 | -76.9% | 67,000 | -63.7% | 0.00% | – |
| Q3 2021 | $1,837,000 | +24.9% | 184,400 | +66.0% | 0.00% | – |
| Q2 2021 | $1,471,000 | +247.8% | 111,076 | +359.4% | 0.00% | – |
| Q1 2021 | $423,000 | -50.5% | 24,176 | -27.6% | 0.00% | – |
| Q4 2020 | $854,000 | +56.1% | 33,392 | +67.0% | 0.00% | – |
| Q2 2020 | $547,000 | +73.7% | 20,000 | 0.0% | 0.00% | – |
| Q1 2020 | $315,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,959,769 | $49,399,000 | 20.45% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,185,869 | $11,811,000 | 9.97% |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $24,879,000 | 7.18% |
| FRAZIER MANAGEMENT LLC | 5,009,219 | $49,892,000 | 3.99% |
| Orbimed Advisors | 6,962,899 | $69,350,000 | 0.76% |
| Boxer Capital, LLC | 1,928,315 | $19,206,000 | 0.67% |
| Vivo Capital, LLC | 539,263 | $5,371,000 | 0.24% |
| Logos Global Management LP | 125,010 | $1,245,000 | 0.09% |
| Weiss Multi-Strategy Advisers LLC | 336,034 | $3,347,000 | 0.07% |
| Virtus ETF Advisers LLC | 14,687 | $146,000 | 0.06% |